Diabetes research funding organisation JDRF has announced the appointment of two new Board Directors, Nadia Swann and Sarah Johnson. Johnson is currently Head of Patient Advocacy, EMEA at IQVIA, a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry. Swann is a former law firm partner with 20 years’ experience in financial regulation, now at the University of Oxford. Existing Board Director Wilson Leech has also been promoted to the position of Vice Chair of the Board.
Menu
